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Abstract 
Introduction — The so called Davson’s equation relates baseline intracranial pressure (ICP) to resistance to cerebrospinal 
fluid outflow (Rout), formation of cerebrospinal fluid (If) and sagittal sinus pressure (PSS) There is a controversy over 
whether this fundamental equation is applicable in patients with normal pressure hydrocephalus (NPH). We investigated 
the relationship between Rout and ICP and also other compensatory, clinical and demographic parameters in NPH patients.  
Method – We carried out a retrospective study of 229 patients with primary NPH who had undergone constant-rate 
infusion studies in our hospital. Data was recorded and processed using ICM+ software. Relationships between variables 
were sought by calculating Pearson product correlation coefficients and p values.  
Results — We found a significant, albeit weak, relationship between ICP and Rout (R=0.17, p=0.0049), Rout and peak-
to-peak amplitude of ICP (AMP) (R=0.27, p=3.577e-05) and Rout and age (R=0.16, p=0.01306).  
Conclusions — The relationship found between ICP and Rout provides indirect evidence to support disturbed 
Cerebrospinal fluid circulation as a key factor in disturbed CSF dynamics in NPH. Weak correlation may indicate that 
other factors: variable Pss and formation of CSF outflow contribute heavily to linear model expressed by Davson’s 
equation.  
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Introduction 
Normal pressure hydrocephalus (NPH) is a syndrome characterised by ventriculomegaly and the clinical triad of gait 
ataxia, dementia and urinary incontinence [1, 16, 24]. Despite this syndrome being first described over 50 years ago and 
presenting an opportunity for symptom improvement following shunt surgery (it is also described as an only kind of 
reversible dementia), we still know little of its pathophysiology and hydrodynamics [5, 6, 24, 28].  
 
The disturbance of cerebral blood flow and autoregulation periventricularly, with increased intensity proximal to the 
ventricles has been shown[22]. A variety of processes, possibly including tissue distortion, accumulation of vasoactive 
and toxic substances, watershed ischaemia and damage in the vasculature could contribute to the pathophysiology and 
clinical presentation of NPH[[11, 12, 22, 24]. The cause of ventricular enlargement in idiopathic NPH (iNPH) is not as 
clear. It is thought to be due to a hydrodynamic deficit, although whether this is due to “cisternal block” or aqueduct 
stenosis or as a problem of cerebrospinal fluid (CSF) absorption due to arachnoid cell hyperplasia and leptomeningeal 
fibrosis, as well as other degenerative changes, is still uncertain[4–6, 13, 25].  
 
The so called “Davson’s equation” is a fundamental equation in the description of CSF hydrodynamics in physiological 
individuals7. It relates baseline intracranial pressure (ICP) to resistance to cerebrospinal fluid outflow (Rout), formation 
of cerebrospinal fluid (If) and sagittal sinus pressure (PSS), as shown below[24]: 
 
ICP = Rout * If + PSS 
 
This equation is valid if ICP is greater than Pss. Below Pss , ICP may have any value.  
 
It has been suggested that a key deficit in NPH is a disturbance in the Rout variable and treatment for NPH, shunt surgery, 
is aimed at manipulating Rout[7–11, 24]. A large Dutch study found that a positive outcome of shunt surgery, as measured 
by gait improvement on the NPH scale and improvement of dementia measured using the Modified Rankin Scale, can be 
predicted by a Rout of 18mmHg/ml/min or more[7]. Other studies found significant improvement in clinical outcomes 
following shunting using lower Rout cut-offs ranging from 13-16mmHg/ml/min[8–10] and a 2015 meta-analysis on Rout 
thresholds for predicting shunt responsiveness concluded that a Rout of 12mmHg/ml/min is most appropriate for accurate 
prediction[23]. Nevertheless, the latest multi-centre European study on NPH found that Rout has no correlation to clinical 
outcome and should not be used to exclude patients from treatmen[29]. Additionally, a 16-patient study, using constant-
rate infusion tests, found no relationship between Rout and ICP measured during overnight monitoring[14]. This has 
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ignited controversy over whether Rout is implicated in NPH and whether Davson’s fundamental equation is applicable to 
patients with NPH.  
 
Davson’s equation (Figure 1) can be positively validated in individual cases. The relationship between variable infusion 
rate and observed pressure  is always linear [15, 24]: 
 
 
Figure 1: Davson’s equation; The relationship between pressure and flow in a healthy, 64-year-old patient. Abscissa: 
the CSF pressure obtained when the flow at each level has stabilised after the initially higher flow rate. Ordinate: the 
corresponding inflow of artificial CSF from the bottle to the patient’s subarachnoid space. There is obviously a 
rectilinear relation between pressure and flow. The horizontal line below the abscisa represents the CSF formation rate 
of 4.6 mm3 s-1 obtained in this patient. The intersection of this ;ine with the regression line thus represents the pressure 
that should have existed if there were no production of CSF and thus not outflow through the arachnoidal villi –that is, 
the pressure of the CSF recipient, mainly the sagittal sinus. Below this pressure no elimination of CSF can occur.  Gop: 
conductance of the CSF outflow pathways.   Reproduced from Ekstedt (1977)15. 
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This study investigates the relationship between ICP and Rout between patients in order to ascertain the validity of 
applying Davson’s equation to NPH patients. In addition, the association between Rout and pulse amplitude of ICP, age, 
sex, aetiology of patients, etc., has been scrutinized  
 
 
Material and Methods 
Patient group 
All patients were retrospectively recruited and had a working diagnosis of possible idiopathic NPH (iNPH), with 
documented radiological evidence of ventriculomegaly on CT and/or on MRI scans, baseline CSF pressure below 
18mmHg and at least two of the three cardinal symptoms of NPH (gait disturbance, cognitive impairment, urinary 
incontinence) including gait disturbance.  They attended Cambridge University Hospital Hydrocephalus Clinic between 
2009-2013 and an infusion test was indicated as part of their work-up and diagnostic criteria according to hospital 
guidelines and in line with National Institute for Health and Clinical Excellence (NICE) guidelines[25]. All subjects were 
provided with an information leaflet and signed individual consent forms. There is some data overlap between this study 
and previous publications from our databases[13, 19, 23]. 
 
Infusion test 
Access was gained via lumbar puncture at the intervertebral space L4-L5 using local anaesthesia or via a previously 
placed Ommaya reservoir (this is a reservoir placed under the scalp alone, with no associated shunt) with the patient lying 
on their side. Connection of a fluid filled pressure transducer (Edwards LifesciencesTM) and pressure amplifier 
(Spiegelberg or Philips) to the LP needle allowed for datapoint recording at a frequency of 30-100Hz, with following 
processing by ICM+ (University of Cambridge Enterprise Ltd)[26]. Once adequate CSF pressure and arterial waveforms 
readings had been achieved, baseline measurements were taken for 10 minutes, followed by infusion of Hartmann’s 
solution at 1.5ml/min until the ICP had plateaued for 5-10minutes. As a safety measure, if ICP increased to 40mmHg or 
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above the infusion was stopped. The total duration of the infusion tests was approximately 30 to 45 minutes. Once the 
infusion test was concluded, a tap test withdrawal of 30 – 50 mls of CSF was carried out prior to removal of LP needle 
and the patient was kept in hospital for observation for 4 hours. An example of a typical infusion test recording and 
analysis can be found in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Example of a typical CSF infusion study recording and analysis of the test results. Upper panel:  Example 
of a typical infusion test recording of a patient referred with possible iNPH.  ICP (upper area) is monitored at baseline 
for 5-10 minutes and is gradually increased by Hartmann’s/Ringer’s infusion until a stable plateau). AMP (fundamental 
amplitude of ICP – lower area)   typically follows the increase of ICP.  Lower panel; Assessment of CSF dynamics using 
CSF models integrated in ICM+ to optimize calculation of Rout and other parameters calculated during infusion test. 
Right curve: solid, curved line represents the theoretical model representing the response of ICP to infusion at each time 
-baseline, during infusion and plateau.  The second line represents the calculations performed by the interpreter of the 
CSF test and which should optimally fit the theoretical mode. Left curve: The solid line represents a similar model, where 
the calculations of the user should fir the Pressure – Volume curve as proposed by Marmarou (1974)19 and integrated in 
ICM+. ICP: Intracranial Pressure, AMP: fundamental amplitude of ICP 
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Patient follow-up & outcome assessment 
After undergoing a CSF infusion test, the patients are followed up by the clinical team to receive a final clinical 
diagnosis and also to decide on whether or not to proceed to shunting or ETV. The clinical criteria used up to 
2013 to make the final diagnosis have been previously reported [20]  and mainly include the Rout (threshold 
of 13 mmHg/min/ml) but also imaging evidence of the proportion of deep white matter lesions and response 
to the tap test. Outcome was assessed using a simple scale[23] and based on a combination of improvement 
primarily and objectively in gait combined with feedback from the patient. Outcome 1 & 2 correspond to 
clinical improvement for 6 and 3 months after shunting respectively, whereas outcome 3 corresponded to no 
clinical improvement.  
 
Statistical Analysis 
Data was recorded and processed using ICM+ software. There is ample evidence in the literature for using Rout estimators 
derived from the computerised CSF infusion test, with values appearing to correlate very well [2, 3, 26, 27]. In a data 
analysis approach, there are two modes of calculating Rout; static mode, derived from the classic formula (ICP plateau – 
ICP baseline) (mmHg) / infusion rate (ml/min), and dynamic mode, which derives from optimising this calculation by 
fitting it to a mathematical model. ICM+ allows for calculation of Rout using both methods. The dynamic calculation is 
almost always preferred, unless there is no optimal fit between our calculations and the mathematical model, in which 
case the dynamic calculation of Rout becomes unreliable and as such it is discarded and the static calculation of Rout is 
used instead.  
All statistical analysis was carried out in R software (version 3.3.3). Relationships between variables were sought by 
calculating Pearson or Spearman product correlation coefficients and p values. Between-group differences (eg different 
outcome groups) were tested using the Wilcoxon signed rank test or the student t-test, after checking for normality and 
confirming parametric assumptions. Multiple linear regression was performed to analyse the influence of other variables 
on the relationships under investigation.  
 
Results 
The study included 229 patients: 137 males and 92 females, male-to-female ratio of approximately 1.5:1. Their age ranged 
from 36 to 96 years [median age 75years, mean age of the cohort was 70.4 (± 13.82) ] at time of the infusion test.  
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The values calculated for Rout, ICP, AMP and age in male and female subgroups are presented in table 1 as mean values 
with standard errors of the mean and level of significance (p-value) when the respective groups are compared.  
 
Table 1: Demographic and mean values of CSF test parameters for male versus female patients. Values are represented 
as mean +/- the standard deviation. Rout: Resistance to CSF outflow. ICP: Intracranial Pressure as recorded at baseline, 
AMP: Fundamental Amplitude of ICP as recorded at baseline.  
 
 
iNPH (N=229) Male (N=137) Female (N=92) p-value 
Age (years) 
70.4 +/- 13.82    
Clinical 
Referral 
Query for suspected 
iNPH 
Referral from 
multiple 
specialists 
Clinical criteria 
and clinical 
assessment 
variable  
 
Clinical 
findings 
Ventriculomegaly in 
CT and/or MRI 
determined by at 
least 1 specialist 
consultant 
+ always 
disturbed gait 
+ ≥1 from the 
Hakim triad 
Dementia 
diagnosed by 
neuropsychologists 
ROUT 
(mmHg*min/ml) 
13.18  +/- 5.53 13.48 +/- 5.5 12.7 +/- 5.57 0.33 
ICP (mmHg) 9.0 +/ - 3.64 9.28 +/- 3.57 8.59 +/- 3.74 0.1449 
AMP (mmHg) 1.01 +/- 0.62 0.98 +/- 0.58 1.06 +/- 0.68 0.4469 
Age (years) 71.25 +/- 13.06 72.33 +/- 10.83 69.64 +/- 15.74 0.8228 
 
 
We found a significant, albeit weak, positive correlation between Rout and ICP (R = 0.17, p=0.0049) as shown in figure
 3A. On the other hand, there was no correlation between Rout and ICP in the female subgroup, but the correlation was 
strong and present in the male subgroup (R=0.26, p=0.002). The correlation between Rout and ICP was stronger when i
nvestigated by multiple linear regression, which took the influence of age into account (R=0.31, p= 5.935e-06).  
Rout was also positively correlated with AMP (R=0.27, p=3.577e-05), as shown in figure 3B and strongly correlated with 
patients’ age (R=0.16, p=0.01306), as shown in figure 3C. The correlation between Rout and age was also absent in the 
male subgroup, but present and strong in the female subgroup (R=0.33, p=0.001).  
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Relationship in different diagnosis & outcome groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Relationship between Rout and different parameters: A: Scatter plot showing resistance to CSF outflow 
versus baseline intracranial pressure. B: scatter plot showing resistance to csf outflow (rout) versus amp at baseline. 
rout: resistance to csf outflow. icpbeg: baseline intracranial pressure. b: rout and amp baseline; elationship between 
Rout and different parameters.C: Resistance to CSF outflow versus age. Rout: resistance to sf outflow.  
 
 
 
Following infusion studies and clinical evaluation,, 149 patients received a final diagnosis of NPH and for 51 did not, 
whereas the rest of the patients  (total of 29) were lost in follow up. 143 were finally shunted or underwent ETV and were 
A B 
C 
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available for follow up in our hydrocephalus clinic. 5 patients had ETV and the remaining 138 had shunt insertion. The 
type of interventional choice was made by the consultant clinician. 119 of those responded well to the CSF diversion 
(outcome =1 or 2) versus 15 who did not demonstrate any improvement (outcome=3). 9 patients were lost in follow-up. 
The CSF infusion studies parameters calculated for different outcome groups are demonstrated in Table 2.  
 
TABLE 2  Mean values of CSF test parameters for patients receiving a clinical diagnosis of iNPH versus patients who 
did not receive one and patients who responded favourably to shunting/ETV (outcome =1 represents sustained clinical 
improvement for >6 months and outcome =2 represents temporary improvement after 3 months but deterioration after 6 
months in our reported scale) vs those who didn’t respond . Values are represented as mean +/- the standard deviation. 
Rout: resistance to CSF outflow. ICP: intracranial pressure as recorded at baseline, AMP: fundamental amplitude of 
ICP as recorded at baseline. .   
 
 
Diagnosed 
(N=149) 
Not Diagnosed 
(N=51) 
p-value 
 
Responders 
(N=119, 
outcome = 1,2) 
Non -responders 
(N=15, outcome 
= 3) 
p-value 
ROUT 
(mmHg*min/ml) 
14.49 +/- 5.45 10.03 +/- 3.63 
 
1.377e-07 
 
 
14.63 +/- 5.32 
 
15.26 +/- 5.5 
 
0.8434 
ICP (mmHg) 9.42 +/- 3.74 8.92 +/- 3.07 0.3363 9.87 +/- 3.69 8.96 +/- 3.57 0.4215 
AMP (mmHg) 0.97 +/- 0.62 1.018 +/- 0.66 0.3413 0.99 +/- 0.60 0.90 +/- 0.58 0.6242 
Age (years) 
69.05 +/- 
12.72 
74.75 +/- 10.11 0.00018 68.57 +/- 12.89 71.4 +/- 10.83                    0.1261 
 
 
 
The correlation between Rout and ICP baseline (ICPbeg) appeared insignificant in the group of patients with a final 
clinical diagnosis of NPH without considering the effect of age (R=0.1 ; p=0.0533), but when age was accounted for the 
correlation became stronger and significant (R=0.3993; p=3.095-06). Therefore, there is a significant correlation between 
Rout and ICPbeg in the 143 patients with a final diagnosis of NPH provided that we take age into consideration. 
Furthermore, the relationship was absent in the patients who did not receive an NPH diagnosis. Similarly, the relationship 
was only present when the interaction between Rout and Age was considered in patients with favourable outcome, that is 
outcome=1 or outcome=1 or 2 (R=0.43; p = 6.302e-06) while being absent in the non-responders (outcome =3). 
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Discussion 
The key finding of this study is a weak but significant correlation between Rout and ICP in a large cohort of iNPH patients. 
This result supports the use of Davson’s equation to model CSF hydrodynamics, however its use without precise 
knowledge of Pss and CSF formation rate is limited. The positive correlation of Rout and ICP provides evidence 
supporting Rout as a key disturbance in NPH. It suggests that Rout is implicated in the pathophysiology in NPH and that 
an elevation of baseline ICP is possible in these cases.  
 
Despite having found a significant correlation, it might not be as strong as would be expected. Possible explanations for 
this could include variations of pressure in the sagittal sinus, CSF formation rate and those cases where baseline ICP was 
lower than Pss, where Davson equation is not valid at all. Pressure in the sagittal sinus is considered a constant parameter, 
determined by central venous pressure[11, 12, 21, 23, 24]. However, despite PSS being constant in one individual, it may 
vary amongst different individuals. Ekstedt et al found PSS to range from 0.7 to 1.35kPa (5.25 – 10.13 mmHg) in 
“physiological” individuals[15, 24]. However, it is currently rare to measure PSS directly. This heterogeneity of PSS values 
in the population could contribute to creating an apparently weaker correlation. Rout was also found to increase with age. 
Similarly, If also remains unmeasured in “physiological” individuals and unknown in hydrocephalic individuals[14, 15, 
24]. If is generally reported as stable at 0.35 ml/min, however we are not aware of any studies with reliable If measurements 
for hydrocephalic individuals or hydrocephalus animal models.  
 
Rout was found to increase with age, in accordance with previous publications on this existing relationship [20, 23]. 
Therefore, we considered whether age could act as a confounding variable between Rout and ICP. We carried out a 
multiple linear regression analysis, which showed a stronger and more statistically significant association between Rout 
and ICP. This influence shows that the correlation between ICP and Rout has multiple influencing factors. Age is known 
as one of these factors. For future consideration, it would be interesting to explore formation rate and PSS further, in order 
to determine the ICP-Rout relationship more holistically. To the best of our knowledge, these parameters and their 
behaviour in NPH patients has not yet been investigated.  
 
Despite Rout, ICP and AMP not differing between previously defined subgroups (males and females) there were 
significant differences in the correlation coefficients calculated for these groups. The male and female subgroups each 
contain a larger number of patients, however sample size is still too small to determine whether the lack of correlation 
calculated is accurate and further study will be required for confirmation. Furthermore, this is a retrospective study 
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involving patients with a working diagnosis of NPH. A future study with follow up of these patients in respect to 
improvement after shunt surgery and confirmation of NPH diagnosis could shed more light on our findings.  
 
Alarmingly, the correlation between Rout and ICPbeg demonstrated an even stronger age dependency in the group of 
patients with a final clinical diagnosis of NPH. This is an interesting finding that could be used to argue in favour of the 
importance of age-adjustment for Rout calculations in hydrocephalic individuals, to assist NPH diagnosis and shunt 
prognostication[17–19, 23]. Finally, the similar behaviour of the correlation in the group of patients who positively 
responded to shunting, that is the strongly age-dependent detection of the correlation, absent in the non-responders, could 
also have additional value to the new chapter of Rout optimisation and CSF dynamics studies in hydrocephalic patients. 
The number of patients in the non-responder group is quite low (N=15), however outcome is not the current focus of this 
study. 
 
Limitations 
We have referred to patients as possible and probable NPH candidates as it is frequently impossible to ascertain whether 
a patient has NPH, pure NPH or NPH plus other co-morbidities. Unfortunately, there is no gold standard for the manner 
in which to accurately diagnose NPH, predict shunt response, to decide to shunt or even how to measure response to 
shunting. Therefore, as there is not always a way to definitively diagnose NPH, it is to be expected that we cannot 
determine with certainty which of our patients had NPH and which did not. It is possible that some of these patients could 
have a different diagnosis, resulting in a wide range of Rout values. The influence of different characteristics, such as co-
morbidities and duration of symptoms should be taken into account but is not always determined in our patients. Finally, 
there are very few patients with no response to shunting, so the results from this analysis are subject to the relevant 
limitations. In the end, the objective truth on the diagnosis of iNPH is unfortunately still open for debate.  
 
As previously reported, the patients referred for infusion studies are referred from a multitude of neurosurgical consultants 
[20]. Therefore, we are unable to report clinical information, pre-and post- operative assessment of the magnitude of the 
symptoms and the patients’ improvement in great detail. This is due to a great loss of data that is part of the retrospective 
nature of the study. However, every patient undergoes thorough investigations by specialists before diagnosis and 
outcome classifications are made. Furthermore, our simple, 3-level scale does not report in detail the magnitude of 
improvement of the patients’ symptoms, despite that the patients have been investigated, monitored and followed-up 
closely in order to determine their management and outcome reflected in our scale. 
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